Autosomal dominant intellectual disability associated with the MED13L gene
https://doi.org/10.21508/1027-4065-2022-67-1-101-107
Abstract
Intellectual disability is a widespread group of diseases with population frequency 1–3%. More than half of intellectual disability cases are due to various genetic causes, including monogenic ones. The paper describes three clinical cases of MED13L-associated intellectual disability with an autosomal dominant inheritance. Novel probably pathogenic variants p.Cys118delinsTrpSer and p.Gln2111fs, as well as the previously described p.Pro866Leu mutation in the MED13L gene (NM_015335), were detected in patients by massive parallel sequencing. А rare familial case with two affected maternal half-siblings was of particular interest since the mutation detected in both children was not found in the mother (blood cells and buccal epithelium were investigated). We assume the presence of gonadal mosaicism in the mother, which allows to recommend families with confirmed cases of MED13L-associated intellectual disability to plan pregnancies with prenatal or preimplantational diagnostics. The disease has been shown to have a wide clinical variability, even intrafamilial.
About the Authors
O. A. LevchenkoRussian Federation
Moscow
G. E. Rudenskaya
Russian Federation
Moscow
T. V. Markova
Russian Federation
Moscow
L. A. Bessonova
Russian Federation
Moscow
A. V. Marakhonov
Russian Federation
Moscow
S. E. Nagieva
Russian Federation
Moscow
O. A. Shchagina
Russian Federation
Moscow
A. V. Lavrov
Russian Federation
Moscow
References
1. A.V., Bannikov A.V., Chausheva A.I., Dadali E.L. Genetics of mental retardation. Rossiyskiy Vestnik Perinatologii i Pediatrii 2016; 61(6): 13–20. (in Russ.) DOI: 10.21508/1027– 4065–2016–61–6–13–20
2. Vissers L., de Ligt J., Gilissen C., Janssen I., Steehouwer M., de Vries P. et al. A de novo paradigm for mental retardation. Nat Publ Gr 2010; 42(12): 1109–1112. DOI: 10.1038/ng.712
3. Muncke N., Jung C., Rüdiger H., Ulmer H., Roeth R., Hubert A. et al. Missense Mutations and Gene Interruption in PROSIT240, a Novel TRAP240-Like Gene, in Patients with Congenital Heart Defect (Transposition of the Great Arteries). Circulation 2003; 108(23): 2843–2850. DOI: 10.1161/ 01.CIR.0000103684.77636.CD
4. Tørring P.M., Larsen M.J., Brasch-Andersen C., Krogh L.N., Kibæk M., Laulund L. et al. Is MED13L-related intellectual disability a recognizable syndrome? Eur J Med Genet 2019; 62(2): 129–136. DOI: 10.1016/j.ejmg.2018.06.014
5. Wieczorek D. Autosomal dominant intellectual disability. Medgen 2018; 30(3): 318–322. DOI: 10.1007/s11825–018– 0206–2
6. The Deciphering Developmental Disorders Study., Fitzgerald T., Gerety S., Jones W., Van Kogelenberg M., King D. et al. Largescale discovery of novel genetic causes of developmental disorders. Nature 2015; 519(7542): 223–228. DOI: 10.1038/ nature14135
7. Ryzhkova O.P., Kardymon O.L., Prohorchuk E.B., Konovalov F.A., Maslennikov A.B., Stepanov V.A. et al. Guidelines for the interpretation of massive parallel sequencing variants (update 2018, v2). Meditsinskaya genetika 2019; 18(2): 3–23. (in Russ.) DOI: 10.25557/2073–7998.2019.02.3–23
8. Smol T., Petit F., Piton A., Keren B., Sanlaville D., Afenjar A. et al. MED13L-related intellectual disability : involvement of missense variants and delineation of the phenotype. Neurogenetics 2018; 19(2): 93–103. DOI: 10.1007/s10048–018– 0541–0
9. Asadollahi R., Zweier M., Gogoll L., Schiffmann R., Sticht H., Steindl K. et al. Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation. Eur J Med Genet 2017; 60(9): 451–464. DOI: 10.1016/j.ejmg.2017.06.004
10. Aoi H., Mizuguchi T., Ceroni J.R., Kim V.E.H., Furquim I., Honjo R.S. et al. Comprehensive genetic analysis of 57 families with clinically suspected Cornelia de Lange syndrome. J Hum Genet 2019; 64(10): 967–978. DOI: 10.1038/s10038– 019–0643-z
11. Utami K.H., Winata C.L., Hillmer A.M., Aksoy I., Long H.T., Liany H. et al. Impaired development of neural-crest cellderived organs and intellectual disability caused by MED13L haploinsufficiency. Hum Mutat 2014; 35(11): 1311–1320. DOI: 10.1002/humu.22636
12. Yamamoto T., Shimojima K., Ondo Y., Shimakawa S., Okamoto N. MED13L haploinsufficiency syndrome: A de novo frameshift and recurrent intragenic deletions due to parental mosaicism. Am J Med Genet Part A 2017; 173(5): 1264– 1269. DOI: 10.1002/ajmg.a.38168
13. Helderman-van Den Enden A.T., de Jong R., den Dunnen J..T, Houwing-Duistermaat J.J., Kneppers A.L., Ginjaar H.B. et al. Recurrence risk due to germ line mosaicism: Duchenne and Becker muscular dystrophy. Clin Genet 2009; 75(4): 465– 472. DOI: 10.1111/j.1399–0004.2009.01173.x
Review
For citations:
Levchenko O.A., Rudenskaya G.E., Markova T.V., Bessonova L.A., Marakhonov A.V., Nagieva S.E., Shchagina O.A., Lavrov A.V. Autosomal dominant intellectual disability associated with the MED13L gene. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2022;67(1):101-107. (In Russ.) https://doi.org/10.21508/1027-4065-2022-67-1-101-107